Since the creation of the International Society of Geriatric Oncology, the proportion of phase III trials reporting at least one analysis dedicated to elderly patients has grown (46.7% between 2011 and 2014 versus 19.3% between 2001 and 2004). However, evidence based data is mostly extracted from subgroup analyses that can only be considered as preliminary evidence.
from Cancer via ola Kala on Inoreader http://ift.tt/294bUpW
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου